These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7085806)

  • 21. [Pathology of apoplexy. 4. The clinical course of a cerebral infarct].
    Okazaki H
    Kangogaku Zasshi; 1980 Jan; 44(1):93-6. PubMed ID: 6767073
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secondary prevention of brain infarction].
    Nagatsuka K; Sawada T
    Nihon Rinsho; 1993 Nov; 51 Suppl():499-504. PubMed ID: 8283708
    [No Abstract]   [Full Text] [Related]  

  • 23. Activated astrocytes display increased 5-HT2a receptor expression in pathological states.
    Wu C; Singh SK; Dias P; Kumar S; Mann DM
    Exp Neurol; 1999 Aug; 158(2):529-33. PubMed ID: 10415157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral infarcts in newborns and infants with cyanotic cardiac anomalies.
    Dambska M; Kuchna I; Wróblewska-Kałuzewska M
    Neuropatol Pol; 1993; 31(1-2):97-102. PubMed ID: 8208445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttraumatic cerebral infarction: incidence, outcome, and risk factors.
    Tawil I; Stein DM; Mirvis SE; Scalea TM
    J Trauma; 2008 Apr; 64(4):849-53. PubMed ID: 18404047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent advances in the diagnosis and management of acute ischemic cerebrovascular disease].
    Rangel-Guerra RA; Martínez HR; Azpiri-López J; Valero-Castillo R; Elizondo-Riojas G; Garza-Mercado R; Tamez-Montes D
    Gac Med Mex; 1997; 133(5):431-53. PubMed ID: 9504071
    [No Abstract]   [Full Text] [Related]  

  • 28. Carotid vulnerable lesions are related to accelerated recurrence for cerebral infarction magnetic resonance imaging study.
    Lin K; Zhang ZQ; Detrano R; Lu B; Fan ZM
    Acad Radiol; 2006 Oct; 13(10):1180-6. PubMed ID: 16979066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses.
    Satoh J; Tabunoki H; Nanri Y; Arima K; Yamamura T
    Neurosci Res; 2006 Sep; 56(1):61-72. PubMed ID: 16797759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms and syndromes in stroke. Prognosis and therapeutic effects are dependent on the cause].
    Norrving B
    Lakartidningen; 1993 Jun; 90(22):2131-4. PubMed ID: 8502065
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia.
    Günther A; Küppers-Tiedt L; Schneider PM; Kunert I; Berrouschot J; Schneider D; Rossner S
    Eur J Neurosci; 2005 Jun; 21(11):3189-94. PubMed ID: 15978027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIAs: the forewarning of stroke.
    Ramirez-Lassepas M
    Geriatrics; 1980 Apr; 35(4):73-83. PubMed ID: 7358280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lacunar infarcts].
    Arboix A; Martí-Vilalta JL
    Rev Clin Esp; 1995 Mar; 195(3):164-71. PubMed ID: 7754151
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment.
    Shinohara Y; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Yamaguchi T; Okudera T
    Cerebrovasc Dis; 2007; 24(2-3):202-9. PubMed ID: 17596689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebrovascular stroke: epidemiology, etiology, physiopathology, diagnosis, course, treatment].
    Amarenco P
    Rev Prat; 1998 Nov; 48(17):1939-52. PubMed ID: 9854399
    [No Abstract]   [Full Text] [Related]  

  • 36. How time dependent is the threshold for cerebral infarction?
    Read SJ; Bladin CF; Yasaka M; Donnan GA
    Stroke; 1996 Oct; 27(10):1918-20. PubMed ID: 8841359
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronomorphology of cerebrovascular disorders].
    Schröder R
    Schriftenr Neurol; 1983; 24():1-159. PubMed ID: 6635584
    [No Abstract]   [Full Text] [Related]  

  • 38. [Apropos of the pathogenesis and localization of cerebral infarctions].
    Shirokova LI
    Vopr Psikhiatr Nevropatol; 1965; 11():116-23. PubMed ID: 5883049
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventive treatment that might reduce the severity of infarctions in risk patients.
    Fieschi C
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S82-6. PubMed ID: 7085806
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current clinical management of cerebrovascular diseases in the elderly].
    Iwamoto T
    Nihon Ronen Igakkai Zasshi; 2007 May; 44(3):283-93. PubMed ID: 17598285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.